Monoclonal Antibodies to the Spike Protein of Feline Infectious Peritonitis Virus Mediate Antibody-dependent Enhancement of Infection of Feline Macrophages

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 1992 Feb 1

PMID 1309922

Citations 115

Authors

C W Olsen

W V Corapi

C K Ngichabe

J D Baines

F W Scott

Affiliations

Soon will be listed here.

Abstract

Antibody-dependent enhancement of virus infection is a process whereby virus-antibody complexes initiate infection of cells via Fc receptor-mediated endocytosis. We sought to investigate antibody-dependent enhancement of feline infectious peritonitis virus infection of primary feline peritoneal macrophages in vitro. Enhancement of infection was assessed, after indirect immunofluorescent-antibody labelling of infected cells, by determining the ratio between the number of cells infected in the presence and absence of virus-specific antibody. Infection enhancement was initially demonstrated by using heat-inactivated, virus-specific feline antiserum. Functional compatibility between murine immunoglobulin molecules and feline Fc receptors was demonstrated by using murine anti-sheep erythrocyte serum and an antibody-coated sheep erythrocyte phagocytosis assay. Thirty-seven murine monoclonal antibodies specific for the nucleocapsid, membrane, or spike proteins of feline infectious peritonitis virus or transmissible gastroenteritis virus were assayed for their ability to enhance the infectivity of feline infectious peritonitis virus. Infection enhancement was mediated by a subset of spike protein-specific monoclonal antibodies. A distinct correlation was seen between the ability of a monoclonal antibody to cause virus neutralization in a routine cell culture neutralization assay and its ability to mediate infection enhancement of macrophages. Infection enhancement was shown to be Fc receptor mediated by blockade of antibody-Fc receptor interaction using staphylococcal protein A. Our results are consistent with the hypothesis that antibody-dependent enhancement of feline infectious peritonitis virus infectivity is mediated by antibody directed against specific sites on the spike protein.

Citing Articles

Antibody-dependent enhancement of coronaviruses.

Tao T, Tian L, Ke J, Zhang C, Li M, Xu X Int J Biol Sci. 2025; 21(4):1686-1704.

PMID: 39990674 PMC: 11844293. DOI: 10.7150/ijbs.96112.

Complement Evasion Protects FCoV from Virus Clearance Within Prototypic FIP Lesions.

Honl A, Felten S, Erber K, Bergmann M, Reese S, Hofmann-Lehmann R Viruses. 2024; 16(11).

PMID: 39599800 PMC: 11598988. DOI: 10.3390/v16111685.

Genetic and Phylogenetic Analysis of Feline Coronavirus in Guangxi Province of China from 2021 to 2024.

Shi K, He M, Shi Y, Long F, Shi Y, Yin Y Vet Sci. 2024; 11(10).

PMID: 39453047 PMC: 11512343. DOI: 10.3390/vetsci11100455.

Preclinical assessment of a recombinant RBD-Fc fusion protein as SARS-CoV-2 candidate vaccine.

Dashti N, Golsaz-Shirazi F, Soltanghoraee H, Zarnani A, Mohammadi M, Imani D Eur J Microbiol Immunol (Bp). 2024; 14(3):228-242.

PMID: 38753442 PMC: 11393645. DOI: 10.1556/1886.2024.00045.

The "original antigenic sin" and its relevance for SARS-CoV-2 (COVID-19) vaccination.

Rijkers G, van Overveld F Clin Immunol Commun. 2024; 1:13-16.

PMID: 38620690 PMC: 8500682. DOI: 10.1016/j.clicom.2021.10.001.

References

Peiris J, Gordon S, Unkeless J, PORTERFIELD J . Monoclonal anti-Fc receptor IgG blocks antibody enhancement of viral replication in macrophages. Nature. 1981; 289(5794):189-91. DOI: 10.1038/289189a0. View

Schlesinger J, Brandriss M . Antibody-mediated infection of macrophages and macrophage-like cell lines with 17D-yellow fever virus. J Med Virol. 1981; 8(2):103-17. DOI: 10.1002/jmv.1890080204. View

Homsy J, Meyer M, Levy J . Serum enhancement of human immunodeficiency virus (HIV) infection correlates with disease in HIV-infected individuals. J Virol. 1990; 64(4):1437-40. PMC: 249276. DOI: 10.1128/JVI.64.4.1437-1440.1990. View

Vennema H, Heijnen L, Zijderveld A, Horzinek M, Spaan W . Intracellular transport of recombinant coronavirus spike proteins: implications for virus assembly. J Virol. 1990; 64(1):339-46. PMC: 249107. DOI: 10.1128/JVI.64.1.339-346.1990. View

Morens D, Venkateshan C, Halstead S . Dengue 4 virus monoclonal antibodies identify epitopes that mediate immune infection enhancement of dengue 2 viruses. J Gen Virol. 1987; 68 ( Pt 1):91-8. DOI: 10.1099/0022-1317-68-1-91. View

Stoddart C, Scott F . Intrinsic resistance of feline peritoneal macrophages to coronavirus infection correlates with in vivo virulence. J Virol. 1989; 63(1):436-40. PMC: 247703. DOI: 10.1128/JVI.63.1.436-440.1989. View

Gimenez H, Keir H, Cash P . In vitro enhancement of respiratory syncytial virus infection of U937 cells by human sera. J Gen Virol. 1989; 70 ( Pt 1):89-96. DOI: 10.1099/0022-1317-70-1-89. View

Krilov L, Anderson L, Marcoux L, Bonagura V, Wedgwood J . Antibody-mediated enhancement of respiratory syncytial virus infection in two monocyte/macrophage cell lines. J Infect Dis. 1989; 160(5):777-82. DOI: 10.1093/infdis/160.5.777. View

Ochiai H, Kurokawa M, Hayashi K, NIWAYAMA S . Antibody-mediated growth of influenza A NWS virus in macrophagelike cell line P388D1. J Virol. 1988; 62(1):20-6. PMC: 250496. DOI: 10.1128/JVI.62.1.20-26.1988. View

10.

Gollins S, PORTERFIELD J . A new mechanism for the neutralization of enveloped viruses by antiviral antibody. Nature. 1986; 321(6067):244-6. DOI: 10.1038/321244a0. View

11.

Petersen N, Boyle J . Immunologic phenomena in the effusive form of feline infectious peritonitis. Am J Vet Res. 1980; 41(6):868-76. View

12.

Daha M, Horzinek M . Antibody, immune complexes, and complement activity fluctuations in kittens with experimentally induced feline infectious peritonitis. Am J Vet Res. 1982; 43(4):666-70. View

13.

Panicali D, Davis S, Weinberg R, Paoletti E . Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin. Proc Natl Acad Sci U S A. 1983; 80(17):5364-8. PMC: 384256. DOI: 10.1073/pnas.80.17.5364. View

14.

Smith G, Murphy B, Moss B . Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters. Proc Natl Acad Sci U S A. 1983; 80(23):7155-9. PMC: 390012. DOI: 10.1073/pnas.80.23.7155. View

15.

King A, Sands J, PORTERFIELD J . Antibody-mediated enhancement of rabies virus infection in a mouse macrophage cell line (P388D1). J Gen Virol. 1984; 65 ( Pt 6):1091-3. DOI: 10.1099/0022-1317-65-6-1091. View

16.

Schlesinger J, Brandriss M . 17D yellow fever virus infection of P388D1 cells mediated by monoclonal antibodies: properties of the macrophage Fc receptor. J Gen Virol. 1983; 64 (Pt 6):1255-62. DOI: 10.1099/0022-1317-64-6-1255. View

17.

Daha M, Horzinek M . Isolation and characterization of feline C3 and evidence for the immune complex pathogenesis of feline infectious peritonitis. J Immunol. 1980; 125(4):1606-10. View

18.

Corapi W, Donis R, Dubovi E . Characterization of a panel of monoclonal antibodies and their use in the study of the antigenic diversity of bovine viral diarrhea virus. Am J Vet Res. 1990; 51(9):1388-94. View

19.

Lai M . Coronavirus: organization, replication and expression of genome. Annu Rev Microbiol. 1990; 44:303-33. DOI: 10.1146/annurev.mi.44.100190.001511. View

20.

Morens D, Halstead S . Measurement of antibody-dependent infection enhancement of four dengue virus serotypes by monoclonal and polyclonal antibodies. J Gen Virol. 1990; 71 ( Pt 12):2909-14. DOI: 10.1099/0022-1317-71-12-2909. View